Within Temptation, fronted by lead singer, Sharon den Adel, have recently signed a worldwide deal with Universal Music Germany, including partnering with Spinefarm Records for North American and the UK. This joint venture comes ahead of the band’s new album, Resist, scheduled for release on December 14, 2018.
This new album features a different vision than other records from Within Temptation’s past, including ten anthemic tracks, featuring ethereal melodies with unforgettable hooks.
“Resist is a true milestone for us. If it wasn’t for Resist, Within Temptation wouldn’t be here anymore,” the band stated.
“With this record, we’ve taken inspiration from modern music and gave it a face — a very dark one,” said singer Sharon den Adel. “Sometimes, it feels that today’s pop music lacks a rebellious edge. Our main goal was to collect pieces from sounds we did like and roughen it up as much as we could, resulting in a surprisingly new musical world that is heavier, dirtier and more futuristic than we’ve ever created before. Resist is our take on metal in a new way: to give modern music its rebellious edge.”
To cultivate a lead-in and rich sound from Resist, the band have released their new and musically powerful single, “The Reckoning.” This single features Jacoby Shaddix from Papa Roach. Listen here.
Pre-orders for Resist are live here.
den Adel also shares that “We are beyond excited to have signed to the biggest record label! Bundling our strength together with such a renewing and thriving force in the music industry, we are sure that we can make magic happen.”
Within Temptation have previously released six studio albums since 1997, and sold more than 3.5 million records, and are known as one of the worlds most successful heavy rock groups. The band has received numerous international awards, including a World Music Award, MTV Europe Music Awards, a Metal Hammer Award, among many others. Their last album, Hydra (2014), landed in the top ten of the album charts in ten countries, and held the sixteenth spot on the American Billboard chart, heralding the band’s most successful US-release to date, with a sold-out US tour.
The band’s European tour kicks off in October, with 35 dates in 18 countries. More dates will be announced soon for around the globe and into 2019.